About Contact Us Careers

MRI Contrast Agents Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3139
Published Date: Aug 30, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the MRI Contrast Agents Landscape

Trivitron Healthcare
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
General Electric Company
Bayer AG
Lantheus Medical Imaging Inc.
Bracco Diagnostic Inc.
Daiichi Sankyo Company
Nano Therapeutics Pvt Ltd
Spago Nanomedical AB
Guerbet SA

Browse Key Market Insights with Data Illustration:

MRI Contrast Agents Market Size & Share, Growth Report 2036

In the News

Author Credits: Radhika Pawar

Report ID: 3139
Published Date: Aug 30, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of MRI contrast agents is estimated at USD 2.23 billion.

MRI Contrast Agents Market size was over USD 2.11 billion in 2023 and is anticipated to reach USD 5.02 billion by 2036, growing at around 6.9% CAGR during the forecast period i.e., between 2024-2036. Rising prevalence of chronic disorders and implementation of MRI examination of early diagnosis will fuel the market growth.

Asia Pacific is anticipated to dominate majority revenue share by 2036, owing to increasing necessity for advanced diagnosis method to detect various disease indications such as neurological disorders, cancer, cardiovascular diseases, and others.

The major players in the market include Bayer AG, GE Healthcare, LLC, Guerbet GmbH, Bracco Imaging SpA, Miltenyi Biotec B.V. & Co. Kg, and more.

Inquiry Before Buying Request Free Sample